Is Prostate Urethral Lift Effective in Patients with Multiple Comorbidities?

Area of Science:

• Urology
• Surgical Innovation
• Patient Outcomes

Background:

• Prostatic urethral lift (PUL) offers a minimally invasive treatment for lower urinary tract symptoms.
• PUL is often considered for patients with comorbidities unsuitable for general anesthesia.
• The efficacy of PUL in patients with significant comorbidities is not well-established.

Purpose of the Study:

• To evaluate the clinical efficacy of prostatic urethral lift (PUL) in patients with multiple comorbidities.
• To compare PUL outcomes in high-comorbidity patients versus healthy individuals.
• To assess the impact of comorbidities on long-term PUL effectiveness.

Main Methods:

• Retrospective observational cohort study of 66 patients undergoing PUL.
• Patients categorized into healthy (Group 1) and high-comorbidity (ASA score ≥3, Group 2) groups.
• Comparison of International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), and post-void residual (PVR) over 2 years.

Main Results:

• Healthy patients (Group 1) showed sustained improvements in IPSS, IPSS quality of life (QoL), and Qmax.
• High-comorbidity patients (Group 2) had non-sustained improvements, except for IPSS QoL.
• 36% of high-comorbidity patients required additional treatment for symptom recurrence.

Conclusions:

• Prostatic urethral lift demonstrates limited therapeutic effect and a high failure rate in patients with multiple comorbidities.
• Comorbidity assessment is essential for preoperative counseling regarding PUL suitability and expected outcomes.
• PUL may not be as effective in complex patient populations compared to healthier individuals.